MedTrace Logo

Clinical Trials

NCT01081262 | ACTIVE_NOT_RECRUITING | PHASE3
50 participants

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2010-10-12
Completion:
2015-02-25
Conditions
  • Borderline Ovarian Mucinous Tumor
  • Ovarian Mucinous Cystadenocarcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Stage IA Fallopian Tube Cancer AJCC v6 and v7
  • Stage IA Ovarian Cancer AJCC v6 and v7
  • Stage IB Fallopian Tube Cancer AJCC v6 and v7
  • Stage IB Ovarian Cancer AJCC v6 and v7
  • Stage IC Fallopian Tube Cancer AJCC v6 and v7
  • Stage IC Ovarian Cancer AJCC v6 and v7
  • Stage IIA Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIA Ovarian Cancer AJCC V6 and v7
  • Stage IIB Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIB Ovarian Cancer AJCC v6 and v7
  • Stage IIC Fallopian Tube Cancer AJCC v6 and v7
  • Stage IIC Ovarian Cancer AJCC v6 and v7
  • Stage IIIA Fallopian Tube Cancer AJCC v7
  • Stage IIIA Ovarian Cancer AJCC v6 and v7
  • Stage IIIB Fallopian Tube Cancer AJCC v7
  • Stage IIIB Ovarian Cancer AJCC v6 and v7
  • Stage IIIC Fallopian Tube Cancer AJCC v7
  • Stage IIIC Ovarian Cancer AJCC v6 and v7
  • Stage IV Fallopian Tube Cancer AJCC v6 and v7
  • Stage IV Ovarian Cancer AJCC v6 and v7
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
Results Available
NCT00977574 | ACTIVE_NOT_RECRUITING | PHASE2
349 participants

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2009-09-14
Completion:
2015-01-31
Conditions
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Recurrent Malignant Uterine Corpus Neoplasm
  • Stage IIIA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
  • Stage IIIB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
  • Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
  • Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
  • Stage IVB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
Results Available
NCT00972478 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
83 participants

Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2010-11-15
Completion:
2015-12-30
Conditions
  • Ann Arbor Stage II Non-Hodgkin Lymphoma
  • Ann Arbor Stage III Non-Hodgkin Lymphoma
  • Ann Arbor Stage IV Non-Hodgkin Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
Results Available
NCT00792948 | ACTIVE_NOT_RECRUITING | PHASE2
97 participants

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2009-09-01
Completion:
2016-06-01
Conditions
  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Adult L1 Acute Lymphoblastic Leukemia
  • Adult L2 Acute Lymphoblastic Leukemia
  • Adult T Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
  • RADIATION
Results Available
NCT00658814 | ACTIVE_NOT_RECRUITING | PHASE2
133 participants

Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2008-12-01
Completion:
2013-06-01
Conditions
  • Acute Myeloid Leukemia
  • Adult Acute Megakaryoblastic Leukemia
  • Adult Acute Monoblastic Leukemia
  • Adult Acute Monocytic Leukemia
  • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • Adult Acute Myeloid Leukemia With Maturation
  • Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22.1); RUNX1-RUNX1T1
  • Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A
  • Adult Acute Myeloid Leukemia Without Maturation
  • Adult Acute Myelomonocytic Leukemia
  • Adult Erythroleukemia
  • Adult Pure Erythroid Leukemia
  • Secondary Acute Myeloid Leukemia
Interventions
  • DRUG
Results Available
NCT00588770 | ACTIVE_NOT_RECRUITING | PHASE3
403 participants

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2008-08-08
Completion:
2018-06-05
Conditions
  • Neck Squamous Cell Carcinoma of Unknown Primary
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Verrucous Carcinoma
  • Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
  • Recurrent Neck Squamous Cell Carcinoma of Unknown Primary
  • Recurrent Oral Cavity Verrucous Carcinoma
  • Recurrent Oropharyngeal Squamous Cell Carcinoma
  • Recurrent Salivary Gland Carcinoma
  • Recurrent Sinonasal Squamous Cell Carcinoma
  • Salivary Gland Squamous Cell Carcinoma
  • Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IV Major Salivary Gland Cancer AJCC v7
  • Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVA Laryngeal Verrucous Carcinoma AJCC v7
  • Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
  • Stage IVA Major Salivary Gland Cancer AJCC v7
  • Stage IVA Oral Cavity Cancer AJCC v6 and v7
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7
  • Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVB Laryngeal Verrucous Carcinoma AJCC v7
  • Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
  • Stage IVB Major Salivary Gland Cancer AJCC v7
  • Stage IVB Oral Cavity Cancer AJCC v6 and v7
  • Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7
  • Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVC Laryngeal Verrucous Carcinoma AJCC v7
  • Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7
  • Stage IVC Major Salivary Gland Cancer AJCC v7
  • Stage IVC Oral Cavity Cancer AJCC v6 and v7
  • Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7
  • Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7
  • Tongue Carcinoma
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
Results Available
NCT00569127 | ACTIVE_NOT_RECRUITING | PHASE3
427 participants

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2007-12-01
Completion:
2015-01-01
Conditions
  • Colorectal Neuroendocrine Tumor G1
  • Gastric Neuroendocrine Tumor G1
  • Neuroendocrine Neoplasm
  • Neuroendocrine Tumor
  • Neuroendocrine Tumor G2
Interventions
  • BIOLOGICAL
  • OTHER
  • DRUG
Results Available
NCT00310180 | ACTIVE_NOT_RECRUITING | PHASE3
10273 participants

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-29
Start Date:
2006-04-07
Completion:
2018-03-02
Conditions
  • Breast Adenocarcinoma
  • Hormone Receptor Positive
  • Stage IA Breast Cancer AJCC v7
  • Stage IB Breast Cancer AJCC v7
  • Stage IIA Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
  • Stage IIIB Breast Cancer AJCC v7
Interventions
  • DRUG
  • OTHER
  • RADIATION
Results Available
NCT00027274 | RECRUITING
4000 participants

Cancer in Inherited Bone Marrow Failure Syndromes

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-29
Start Date:
2001-11-28
Conditions
  • Diamond Blackfan Anemia
  • Dyskeratosis Congenita
  • Fanconi Anemia
  • Shwachman Diamond Syndrome
  • Inherited Bone Marrow Failure Syndrome, Aplastic Anemia
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page